Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step .
暂无分享,去创建一个
P. Oettgen | A. Boyle | J. Hare | S. Schulman | Steven P. Schulman | Joshua M. Hare | Andrew J. Boyle | P. Oettgen
[1] R. Whitbourn,et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. , 2006, International journal of cardiology.
[2] H. Johnsen,et al. Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial , 2006, Circulation.
[3] K. Moore,et al. Stem Cells and Their Niches , 2006, Science.
[4] A. Ganser,et al. Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial , 2006, Circulation.
[5] M. Schwaiger,et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. , 2006, JAMA.
[6] J. Degaute,et al. Myocardial Homing of Nonmobilized Peripheral‐Blood CD34+ Cells After Intracoronary Injection , 2006, Stem cells.
[7] S. Dymarkowski,et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.
[8] N. Freemantle,et al. Clinical trials update from the American Heart Association: REPAIR‐AMI, ASTAMI, JELIS, MEGA, REVIVE‐II, SURVIVE, and PROACTIVE , 2006, European journal of heart failure.
[9] Nicholas C. Ide,et al. Trial Registration at ClinicalTrials.gov between May and October 2005. , 2005, The New England journal of medicine.
[10] M. Baker. Stem cell therapy or snake oil? , 2005, Nature Biotechnology.
[11] B. Koplan,et al. Cardiology patient page. Atrial flutter. , 2005, Circulation.
[12] F. Mouquet,et al. Restoration of Cardiac Progenitor Cells After Myocardial Infarction by Self-Proliferation and Selective Homing of Bone Marrow–Derived Stem Cells , 2005, Circulation research.
[13] P. Wernet,et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. , 2005, Journal of the American College of Cardiology.
[14] E. Yeh,et al. The pleiotropic effects of statins , 2005, Current opinion in cardiology.
[15] J. Hare,et al. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy , 2005, Basic Research in Cardiology.
[16] F. Emmrich,et al. Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion: First Randomized and Placebo-Controlled Study , 2005, Circulation research.
[17] B. Griffith,et al. Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up , 2005, Circulation.
[18] W. Wijns,et al. Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety , 2005, Circulation.
[19] D. Spitkovsky,et al. Cell Transplantation Improves Ventricular Function After a Myocardial Infarction: A Preclinical Study of Human Unrestricted Somatic Stem Cells in a Porcine Model , 2005, Circulation.
[20] H. Ikeda,et al. Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium. , 2005, Circulation.
[21] Joshua M Hare,et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Larry Kedes,et al. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. , 2005, Cardiovascular research.
[23] Frank P Barry,et al. Mesenchymal stem cells avoid allogeneic rejection , 2005, Journal of Inflammation.
[24] C. Henrikson,et al. Antiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation , 2005, Circulation research.
[25] H. Figulla,et al. Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. , 2005, American heart journal.
[26] D. Katritsis,et al. CORONARY ARTERY DISEASE Original Studies Transcoronary Transplantation of Autologous Mesenchymal Stem Cells and Endothelial Progenitors Into Infarcted Human Myocardium , 2005 .
[27] Daria Nurzynska,et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Fiszer,et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. , 2005, European heart journal.
[29] Gwang Lee,et al. Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.
[30] D. García-Olmo,et al. A Phase I Clinical Trial of the Treatment of Crohn’s Fistula by Adipose Mesenchymal Stem Cell Transplantation , 2005, Diseases of the colon and rectum.
[31] J. Cigudosa,et al. Spontaneous human adult stem cell transformation. , 2005, Cancer research.
[32] Nan Ma,et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. , 2005, Cardiovascular research.
[33] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[34] U. Ikeda,et al. Repair of Infarcted Myocardium Mediated by Transplanted Bone Marrow–Derived CD34+ Stem Cells in a Nonhuman Primate Model , 2005, Stem cells.
[35] Y. Suematsu,et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. , 2005, Biochemical and biophysical research communications.
[36] Karl-Ludwig Laugwitz,et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages , 2005, Nature.
[37] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[38] H. Arnesen,et al. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects , 2005, Scandinavian cardiovascular journal : SCJ.
[39] G. Fonarow,et al. Feasibility and Safety of Autologous Myoblast Transplantation in Patients with Ischemic Cardiomyopathy , 2005, Cell transplantation.
[40] C. Nienaber,et al. Transcatheter Transplantation of Autologous Skeletal Myoblasts in Postinfarction Patients with Severe Left Ventricular Dysfunction , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[41] M. Kurpisz,et al. Autologous skeletal myoblasts for myocardial regeneration. , 2004, Journal of interventional cardiology.
[42] Deborah Burstein,et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction , 2004, Magnetic resonance in medicine.
[43] M. Capogrossi,et al. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. , 2004, The Annals of thoracic surgery.
[44] Giulio Cossu,et al. Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.
[45] W. Hofmann,et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.
[46] J. García-Sancho,et al. Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction , 2004, Circulation research.
[47] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.
[48] D. Fiszer,et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. , 2004, American heart journal.
[49] S. Homma,et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. , 2004, American journal of physiology. Heart and circulatory physiology.
[50] P. Wernet,et al. A New Human Somatic Stem Cell from Placental Cord Blood with Intrinsic Pluripotent Differentiation Potential , 2004, The Journal of experimental medicine.
[51] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[52] M. Pittenger,et al. Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.
[53] Fei Ye,et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. , 2004, The American journal of cardiology.
[54] C. Nienaber,et al. CABG and bone marrow stem cell transplantation after myocardial infarction. , 2004, The Thoracic and cardiovascular surgeon.
[55] Moustapha Hassan,et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.
[56] B. Fleischmann,et al. Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.
[57] I. Weissman,et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.
[58] David A. Williams,et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.
[59] K. Chien. Stem cells: Lost in translation , 2004, Nature.
[60] P. Anversa,et al. Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation , 2004, Circulation research.
[61] J. Mill,et al. Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts. , 2004, American journal of physiology. Heart and circulatory physiology.
[62] M. Greeley,et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs , 2004, The Lancet.
[63] Hyun-Jai Cho,et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.
[64] E. Pektok,et al. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[65] M. Galiñanes,et al. Autotransplantation of Unmanipulated Bone Marrow into Scarred Myocardium is Safe and Enhances Cardiac Function in Humans , 2004, Cell transplantation.
[66] P. Menasché. Skeletal myoblast transplantation for cardiac repair , 2004, Expert review of cardiovascular therapy.
[67] Patrick W Serruys,et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. , 2003, Journal of the American College of Cardiology.
[68] R. Weisel,et al. Cell transplantation to prevent heart failure: a comparison of cell types. , 2003, The Annals of thoracic surgery.
[69] A. Zeiher,et al. Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging , 2003, Circulation.
[70] F. Prósper,et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. , 2003, European heart journal.
[71] Michael D. Schneider,et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[72] D. Torella,et al. Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.
[73] S. Gambhir,et al. Molecular Imaging of Cardiac Cell Transplantation in Living Animals Using Optical Bioluminescence and Positron Emission Tomography , 2003, Circulation.
[74] J. Kantelip,et al. Mesenchymal Progenitor Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Rat Cellular Cardiomyoplasty Model , 2003, Circulation.
[75] M. Ashraf,et al. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. , 2003, Journal of molecular and cellular cardiology.
[76] Elliot R. McVeigh,et al. Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.
[77] J. Ingwall,et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.
[78] J. Hata,et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. , 2003, Experimental cell research.
[79] Tao-Sheng Li,et al. The Safety and Feasibility of the Local Implantation of Autologous Bone Marrow Cells for Ischemic Heart Disease , 2003, Journal of cardiac surgery.
[80] Shahin Rafii,et al. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.
[81] M. Cerqueira,et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. , 2003, Journal of the American College of Cardiology.
[82] Ergin Atalar,et al. In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.
[83] James T. Willerson,et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.
[84] M. Rubart,et al. Myocyte and myogenic stem cell transplantation in the heart. , 2003, Cardiovascular research.
[85] A. Hagège,et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.
[86] F. Pagani,et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. , 2003, Journal of the American College of Cardiology.
[87] J. Mosca,et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. , 2003, Journal of biomedical science.
[88] A. Hagège,et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy , 2003, The Lancet.
[89] Hung-Fat Tse,et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation , 2003, The Lancet.
[90] Bernd Westphal,et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.
[91] Yong-Fu Xiao,et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. , 2002, The Annals of thoracic surgery.
[92] Alon Spira,et al. High-Resolution Electrophysiological Assessment of Human Embryonic Stem Cell-Derived Cardiomyocytes: A Novel In Vitro Model for the Study of Conduction , 2002, Circulation research.
[93] P. Wernet,et al. Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.
[94] A. Terzic,et al. Stem cell differentiation requires a paracrine pathway in the heart , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[95] A. Hagège,et al. Long-Term Efficacy of Myoblast Transplantation on Regional Structure and Function After Myocardial Infarction , 2002, Circulation.
[96] Yong-Fu Xiao,et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. , 2002, Journal of applied physiology.
[97] L. Muul,et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[98] F. Gámiz,et al. Electron transport in strained Si inversion layers grown on SiGe-on-insulator substrates , 2002 .
[99] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[100] W. Baumgartner,et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.
[101] K. Alitalo,et al. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. , 2002, Journal of cell science.
[102] E. Sim,et al. Transformation of the Adult Human Mesenchymal Stem Cells into Cardiomyocyte-Like Cells in Vivo , 2002 .
[103] J. Vacanti,et al. Percutaneous transvenous cellular cardiomyoplasty , 2002 .
[104] Larry Kedes,et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. , 2002, Journal of molecular and cellular cardiology.
[105] Janita F. J. Vos,et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. , 2001, European heart journal.
[106] Benno J. Rensing,et al. Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up , 2001, Circulation.
[107] G. Cossu,et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[108] A. Kosaki,et al. Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines , 2001, Circulation.
[109] Federica Limana,et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[110] L Gepstein,et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.
[111] M. Entman,et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.
[112] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[113] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[114] A. Hagège,et al. Myoblast transplantation for heart failure , 2001, The Lancet.
[115] Jun Yamashita,et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.
[116] P. Conget,et al. Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.
[117] L. Kedes,et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. , 2000, Journal of the American College of Cardiology.
[118] S. Rafii,et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.
[119] A. Faggiotto,et al. State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action. , 1999, Hypertension.
[120] S. Ogawa,et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.
[121] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[122] Doris A Taylor,et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.
[123] P. Lansdorp,et al. Biology of Human Umbilical Cord Blood‐Derived Hematopoietic Stem/Progenitor Cells , 1998, Stem cells.
[124] J. Kearney,et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.
[125] A. Eichmann,et al. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[126] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[127] S M Schwartz,et al. Skeletal myoblast transplantation for repair of myocardial necrosis. , 1996, The Journal of clinical investigation.
[128] E. Dejana,et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. , 1996, Blood.
[129] G. Koh,et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.
[130] Thomas N. Sato,et al. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[131] G. Koh,et al. Differentiation and long-term survival of C2C12 myoblast grafts in heart. , 1993, The Journal of clinical investigation.
[132] R. C. Chiu,et al. Cell Transplantation for Myocardial Repair: An Experimental Approach , 1992, Cell transplantation.
[133] W. Siegenthaler,et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.
[134] A. Grüntzig. TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS , 1978, The Lancet.
[135] A. Grüntzig,et al. [The percutaneous dilatation of chronic coronary stenoses--experiments and morphology]. , 1977, Schweizerische medizinische Wochenschrift.
[136] B. Gandevia,et al. DECLARATION OF HELSINKI , 1964, Definitions.
[137] Daniel J Garry,et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. , 2004, Developmental biology.
[138] Paul D. Kessler,et al. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.
[139] J. Morgan,et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. , 2002, Journal of applied physiology.
[140] L. Samuelson,et al. Ultrastructure and cell-cell coupling of cardiac myocytes differentiating in embryonic stem cell cultures. , 1997, Cell motility and the cytoskeleton.
[141] A. Caplan,et al. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.
[142] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .
[143] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.